NCT00911274View on ClinicalTrials.gov

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

Mycophenolate Mofetil

250 mg Capsule

DRUG

CellCept®

250 mg Capsule

Trial Locations (1)

78759

Cedra Clinical Research, LLC, Austin

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00911274 - Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter